Skip to main content
Log in

Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome

  • Research Note
  • Published:
Journal of Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Arriagada C., Bustamante M., Atwater I., Rojas E., Caviedes R. and Caviedes P. 2010 Apoptosis is directly related to intracellular amyloid accumulation in a cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome. Neurosci. Lett. 470, 81–85.

    Article  PubMed  CAS  Google Scholar 

  • Elmore S. 2007 Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495–516.

    Article  PubMed  CAS  Google Scholar 

  • Elsayed S. M. and Elsayed G. M. 2009 Phenotype of apoptotic lymphocytes in children with Down syndrome. Immun. Ageing 6, 6–12.

    Article  Google Scholar 

  • Engidawork E. and Lubec G. 2001 Protein expression in Down syndrome brain. Amino Acids. 21, 331–361.

    Article  PubMed  CAS  Google Scholar 

  • Fromage B. and Anglade P. 2002 The aging of Down’s syndrome subjects. Encephale 28, 212–226.

    PubMed  CAS  Google Scholar 

  • Gulesserian T., Engidawork E., Yoo B. C., Cairns N. and Lubec G. 2001 Alteration of caspases and other apoptosis regulatory proteins in Down syndrome. J. Neural Transm. Suppl. 61, 163–179.

    PubMed  Google Scholar 

  • Hu W. and Kavanagh J. J. 2003 Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 4, 721–729.

    Article  PubMed  CAS  Google Scholar 

  • Inoue M., Takahashi K., Niide O., Shibata M., Fukuzawa M. and Ra C. 2005 LDOC1, a novel MZF-1-interacting protein, induces apoptosis. FEBS Lett. 579, 604–608.

    Article  PubMed  CAS  Google Scholar 

  • Lawson M. J. and Zhang L. 2009 Sexy gene conversions: locating gene conversions on the X-chromosome. Nucleic Acids Res. 37, 4570–4589.

    Article  PubMed  CAS  Google Scholar 

  • Livak K. J. and Schmittgen T. D. 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 4, 402–408.

    Article  Google Scholar 

  • Lubec G. and Engidawork E. 2002 The brain in Down syndrome (TRISOMY 21). J. Neurol. 249, 1347–1356.

    Article  PubMed  CAS  Google Scholar 

  • Lynn K. S., Li L. L., Lin Y. J., Wang C. H., Sheng S. H., Lin J. H. et al. 2009 A neural network model for constructing endophenotypes of common complex diseases: an application to male young-onset hypertension microarray data. Bioinformatics 25, 981–988.

    Article  PubMed  CAS  Google Scholar 

  • Mauro M. O., Sartori D., Oliveira R. J., Ishii P. L., Mantovani M. S. and Ribeiro L. R. 2011 Activity of selenium on cell proliferation, cytotoxicity, and apoptosis and on the expression of CASP9, BCL-XL and APC in intestinal adenocarcinoma cells. Mutat. Res. 715, 7–12.

    Article  PubMed  CAS  Google Scholar 

  • Mizutani K., Koike D., Suetsugu S. and Takenawa T. 2001 WAVE3 functions as a negative regulator of LDOC1. J. Biochem. 138, 639–646.

    Article  Google Scholar 

  • Nagasaki K., Manabe T., Hanzawa H., Maass N., Tsukada T. and Yamaguchi K. 1999 Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett. 140, 227–234.

    Article  PubMed  CAS  Google Scholar 

  • Nagasaki K., Schem C., von Kaisenberg C., Biallek M., Rösel F., Jonat W. et al. 2003 Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int. J. Cancer 105, 454–458.

    Article  PubMed  CAS  Google Scholar 

  • Seidl R., Bidmon B., Bajo M., Yoo P. C., Cairns N., La Casse E. C. et al. 2001 Evidence for apoptosis in the fetal Down syndrome brain. J. Child Neurol. 16, 438–442.

    PubMed  CAS  Google Scholar 

  • Sharp A. J., Locke D. P., McGrath S. D., Cheng Z., Bailey J. A., Vallente R. U. et al. 2005 Segmental duplications and copy-number variation in the human genome. Am. J. Hum. Genet. 77, 78–88.

    Article  PubMed  CAS  Google Scholar 

  • Shaw C. J. and Lupski J. R. 2004 Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum. Mol. Genet. 1, 57–64.

    Article  Google Scholar 

  • Wisniewski K. E., Dalton A. J., McLachlan C., Wen G. Y. and Wisniewski H. M. 1985 Alzheimer’s disease in Down’s syndrome: clinicopathologic studies. Neurology 35, 957–961.

    Article  PubMed  CAS  Google Scholar 

  • Yoo B. C., Vlkolinsky R., Engidawork E., Cairns N., Fountoulakis M. and Lubec G. 2001 Differential expression of molecular chaperones in brain of patients with Down syndrome. Electrophoresis 22, 233–241.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to PAOLO BOSCO.

Additional information

These authors contributed equally to this work. (Michele Salemi and Concetta Barone)

[Salemi M., Barone C., Romano C., Ridolfo F., Salluzzo R., Scillato F., Scavuzzo C., Caraci F., Calogero A. E., Romano C. and Bosco P. 2012 Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome. J. Genet. 91, xx–xx]

Rights and permissions

Reprints and permissions

About this article

Cite this article

SALEMI, M., BARONE, C., ROMANO, C. et al. Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome. J Genet 91, 95–98 (2012). https://doi.org/10.1007/s12041-012-0134-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-012-0134-x

Keywords

Navigation